Supernus Pharmaceuticals Inc. News
Supernus Higher as Pediatric ADHD Drug Is Cleared by FDA
Supernus shares are higher after the Food and Drug Administration cleared the company to market a new ADHD drug for children.
XL Fleet, Supernus: 5 Top Gainers for Wednesday
Supernus, XL Fleet, Energous, Ocugen and Vivopower are five top stock gainers for Wednesday.
Supernus Up on Report of Progress With ADHD Treatment
Supernus said that a Phase 3 trial 'met the primary endpoint ... compared to placebo in improving the symptoms of ADHD.'
Biogen, UnitedHealth: 5 Top Stock Gainers for Wednesday
Super Micro Computer, Biogen, Neurocrine Biosciences, Supernus Pharmaceuticals and UnitedHealth.
CVS Health, Coca-Cola, Norfolk Southern: 'Mad Money' Lightning Round
Jim Cramer is bullish on CVS Health, Coca-Cola, Norfolk Southern, IBM and Randgold Resources.
Morningstar's Five Coping Mechanisms for Bear Market
The S&P 500 is in a bear market, having lost 20% so far this year. So what’s an investor to do?
Economist Roubini: Why Stocks Poised for 50% Wipeout
The stock market is off to its worst start to a year since 1962, with the S&P 500 dropping 21% in the first half of 2022.
Who Is the Mystery Crypto Queen on the Run After an Alleged Scam?
The FBI is offering anyone who helps arrest OneCoin co-founder Dr. Ruja Ignatova $100,000.